{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:32:16Z","timestamp":1793151136972,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["KA 5390\/2-1"],"award-info":[{"award-number":["KA 5390\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhepr.2026.101891","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:59:33Z","timestamp":1778245173000},"page":"101891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4495-1724","authenticated-orcid":false,"given":"Janine","family":"Kah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Staffeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Stefanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4030-7431","authenticated-orcid":false,"given":"Gregor","family":"Mattert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassilo","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7843-9334","authenticated-orcid":false,"given":"Maximilian","family":"Vo\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelius","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmus","family":"Heumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Dammermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-2242","authenticated-orcid":false,"given":"Sarah","family":"Kammerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Heiner","family":"K\u00fcpper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-1539","authenticated-orcid":false,"given":"Pablo","family":"Villavicencio-Lorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-6689","authenticated-orcid":false,"given":"Maura","family":"Dandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"L\u00fcth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.101891_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101891_bib2","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3390\/cancers16112034","article-title":"Hepatocellular carcinoma: beyond the border of advanced stage therapy","volume":"16","author":"Zarlashat","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jhepr.2026.101891_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s44355-025-00018-y","article-title":"Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models","volume":"2","author":"Desert","year":"2025","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhepr.2026.101891_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2026.101891_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jhepr.2026.101891_bib6","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jhep.2015.03.007","article-title":"Biology of the immunomodulatory molecule HLA-G in human liver diseases","volume":"62","author":"Amiot","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101891_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-024-04938-w","article-title":"Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects","volume":"22","author":"Wang","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.jhepr.2026.101891_bib8","first-page":"60","article-title":"Soluble HLA-G, its diagnostic and prognostic value and potential target molecule for future therapy in cancer","volume":"122","author":"Kluckova","year":"2021","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.jhepr.2026.101891_bib9","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.3390\/ijms21124528","article-title":"HLA-G: a new immune checkpoint in cancer?","volume":"21","author":"Krijgsman","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.101891_bib10","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1007\/s13277-015-3669-7","article-title":"Down-expression of miR-152 lead to impaired anti-tumor effect of NK via upregulation of HLA-G","volume":"37","author":"Bian","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jhepr.2026.101891_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.humimm.2023.05.002","article-title":"HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population","volume":"84","author":"Okumura","year":"2023","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhepr.2026.101891_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/v17050653","article-title":"Classification of the LC4 primarily-like cell line\u2014recapitulating a CDK4 overexpressing immune evasive HIV-HCV-induced HCC","volume":"17","author":"Kah","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.jhepr.2026.101891_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/cells13010082","article-title":"Generating patient-derived HCC cell lines suitable for predictive in vitro and in vivo drug screening by orthotopic transplantation","volume":"13","author":"Staffeldt","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jhepr.2026.101891_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cbin.10574","article-title":"Primary-like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures","volume":"40","author":"Herzog","year":"2016","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jhepr.2026.101891_bib16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3109\/00498254.2012.675093","article-title":"Generation of proliferating human hepatocytes using Upcyte\u00ae technology: characterisation and applications in induction and cytotoxicity assays","volume":"42","author":"Burkard","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jhepr.2026.101891_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096533","article-title":"Matrix conditions and KLF2-dependent induction of heme oxygenase-1 modulate inhibition of HCV replication by fluvastatin","volume":"9","author":"Wuestenberg","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2026.101891_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcmgh.2017.07.003","article-title":"Hepatitis B virus activates signal transducer and activator of transcription 3 supporting hepatocyte survival and virus replication","volume":"4","author":"H\u00f6sel","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.101891_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jhep.2013.10.021","article-title":"Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration","volume":"60","author":"Allweiss","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.101891_bib20","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15038263","article-title":"HLA-G genetic variants and hepatocellular carcinoma: a meta-analysis","volume":"15","author":"Coelho","year":"2016","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jhepr.2026.101891_bib21","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.gendis.2021.06.004","article-title":"HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: implications in personal medicine","volume":"9","author":"Adolf","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.jhepr.2026.101891_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/gene.2009.74","article-title":"The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes","volume":"11","author":"Castelli","year":"2010","journal-title":"Genes Immun"},{"key":"10.1016\/j.jhepr.2026.101891_bib23","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fimmu.2020.01178","article-title":"HLA-G genotype\/expression\/disease association studies: success, hurdles, and perspectives","volume":"11","author":"Amodio","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2026.101891_bib24","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1245\/s10434-007-9464-y","article-title":"Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma","volume":"14","author":"Yie","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhepr.2026.101891_bib25","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhepr.2026.101891_bib26","article-title":"HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx","volume":"6","author":"Ringelhan","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2026.101891_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/734068","article-title":"Transcriptional and posttranscriptional regulations of the HLA-G gene","volume":"2014","author":"Castelli","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jhepr.2026.101891_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0962-8924(01)02206-1","article-title":"Apoptotic DNA fragmentation and tissue homeostasis","volume":"12","author":"Zhang","year":"2002","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.jhepr.2026.101891_bib29","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ccell.2025.09.006","article-title":"Cell-free DNA fragmentomics in cancer","volume":"43","author":"Tsui","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhepr.2026.101891_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.livres.2024.05.004","article-title":"Hepatitis B virus as a risk factor for hepatocellular carcinoma: there is still much work to do","volume":"8","author":"Abdelhamed","year":"2024","journal-title":"Liver Res"},{"key":"10.1016\/j.jhepr.2026.101891_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.597468","article-title":"The role of HLA-G in tumor escape: manipulating the phenotype and function of immune cells","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2026.101891_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-97406-4","article-title":"Human leukocyte antigen-G in hepatocellular carcinoma driven by chronic viral hepatitis or steatotic liver disease","volume":"15","author":"Mocci","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.101891_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-0039.2011.01814.x","article-title":"Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma","volume":"79","author":"Park","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jhepr.2026.101891_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10238-012-0214-5","article-title":"Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection","volume":"14","author":"Han","year":"2014","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jhepr.2026.101891_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.826074","article-title":"Role of HLA-G in viral infections","volume":"13","author":"Jasinski-Bergner","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2026.101891_bib36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00018-010-0580-7","article-title":"Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association","volume":"68","author":"Donadi","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jhepr.2026.101891_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84508","article-title":"The CD73 immune checkpoint promotes tumor cell metabolic fitness","volume":"12","author":"Allard","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.jhepr.2026.101891_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-024-01364-2","article-title":"Trogocytosis-mediated immune evasion in the tumor microenvironment","volume":"57","author":"Kim","year":"2025","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhepr.2026.101891_bib39","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.emboj.7601570","article-title":"Trogocytosis-based generation of suppressive NK cells","volume":"26","author":"Caumartin","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.jhepr.2026.101891_bib40","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2006-05-024547","article-title":"Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells","volume":"109","author":"LeMaoult","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jhepr.2026.101891_bib41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jhepr.2026.101891_bib42","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.5604\/17322693.1220994","article-title":"PD1\/PD1L pathway, HLA-G and T regulatory cells as new markers of immunosuppression in cancers","volume":"70","author":"W\u0142asiuk","year":"2016","journal-title":"Postepy Hig Med Dosw"},{"key":"10.1016\/j.jhepr.2026.101891_bib43","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2026.101891_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013313","article-title":"Unlocking the promise of innate biology through the HLA-G\/ILT2\/ILT4 pathway","volume":"14","author":"Beers","year":"2026","journal-title":"J Immunother Cancer"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592600162X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592600162X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:39:44Z","timestamp":1793147984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592600162X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S258955592600162X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101891","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.101891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101891"}}